NASDAQ:CELG - Celgene Price Target & Analyst Ratings

Get Started

$90.69 +0.01 (+0.01 %)

(As of 02/18/2019 08:17 AM ET)

Previous Close$90.68

Today's Range$89.49 - $91.50

52-Week Range$58.59 - $96.95

Volume8.13 million shs

Average Volume13.24 million shs

Market Capitalization$63.58 billion

P/E Ratio11.92

Dividend YieldN/A

Beta1.72

Celgene (NASDAQ:CELG) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

25 Wall Street analysts have issued ratings and price targets for Celgene in the last 12 months. Their average twelve-month price target is $107.00, suggesting that the stock has a possible upside of 17.98%. The high price target for CELG is $150.00 and the low price target for CELG is $77.00. There are currently 10 hold ratings and 15 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.60	2.63	2.59	2.56
Ratings Breakdown:	0 Sell Rating(s) 10 Hold Rating(s) 15 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 9 Hold Rating(s) 15 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 10 Hold Rating(s) 18 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 12 Hold Rating(s) 19 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$107.00	$107.6667	$115.5238	$121.20
Price Target Upside:	17.98% upside	33.86% upside	62.96% upside	34.97% upside

Celgene (NASDAQ:CELG) Consensus Price Target History

Price Target History for Celgene (NASDAQ:CELG)

Celgene (NASDAQ:CELG) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
2/1/2019	Jefferies Financial Group	Downgrade	Buy ➝ Hold	$95.00	Low
1/31/2019	Cantor Fitzgerald	Reiterated Rating	Buy	$100.00	Medium
1/4/2019	Robert W. Baird	Upgrade	Neutral ➝ Outperform	$92.00	High
1/3/2019	Goldman Sachs Group	Upgrade	Sell ➝ Neutral	$71.00 ➝ $88.00	High
1/3/2019	Wells Fargo & Co	Lower Price Target	Market Perform ➝ Market Perform	$90.00 ➝ $84.00	High
1/3/2019	Canaccord Genuity	Downgrade	Buy ➝ Hold		High
1/3/2019	Leerink Swann	Downgrade	Outperform ➝ Market Perform		High
12/20/2018	BTIG Research	Initiated Coverage	Neutral ➝ Neutral		High
12/19/2018	Morgan Stanley	Lower Price Target	Equal Weight ➝ Equal Weight	$93.00 ➝ $88.00	Medium
12/17/2018	Citigroup	Lower Price Target	Neutral ➝ Neutral	$100.00 ➝ $77.00	Low
10/30/2018	Mizuho	Set Price Target	Buy	$117.00	Medium
10/27/2018	UBS Group	Set Price Target	Buy	$94.00	Medium
10/25/2018	JPMorgan Chase & Co.	Reiterated Rating	Buy		Low
7/27/2018	SunTrust Banks	Reiterated Rating	Hold	$101.00	Low
7/10/2018	Cowen	Reiterated Rating	Buy	$150.00	Low
6/18/2018	Standpoint Research	Upgrade	Hold ➝ Buy		Low
5/23/2018	Argus	Downgrade	Buy ➝ Hold		Low
5/23/2018	Sanford C. Bernstein	Upgrade	Market Perform ➝ Outperform	$102.00	Low
5/7/2018	Royal Bank of Canada	Downgrade	Top Pick ➝ Outperform	$120.00	High
5/6/2018	Barclays	Set Price Target	Buy	$107.00	Medium
5/5/2018	Credit Suisse Group	Set Price Target	Buy	$129.00	Medium
4/30/2018	Evercore ISI	Reiterated Rating	Buy		Low
2/28/2018	BMO Capital Markets	Lower Price Target	Outperform ➝ Outperform	$144.00 ➝ $139.00	High
2/28/2018	William Blair	Reiterated Rating	Buy		High
2/28/2018	Stifel Nicolaus	Reiterated Rating	Buy ➝ Buy	$130.00 ➝ $128.00	High
1/18/2018	Piper Jaffray Companies	Reiterated Rating	Hold	$104.00	Low
1/10/2018	Guggenheim	Reiterated Rating	Buy	$147.00	Low
1/8/2018	Deutsche Bank	Set Price Target	Hold	$110.00	Low
1/8/2018	Oppenheimer	Set Price Target	Buy	$166.00	High
1/5/2018	Bank of America	Downgrade	Buy ➝ Neutral	$104.68 ➝ $120.00	Medium
12/8/2017	Atlantic Securities	Upgrade	Neutral ➝ Overweight		High
10/27/2017	JMP Securities	Downgrade	Outperform ➝ Market Perform		N/A

(Data available from 2/18/2017 forward)

This page was last updated on 2/18/2019 by MarketBeat.com Staff

Featured Article: Marijuana Stocks Investing Considerations